Clinical Orthopaedics and Related Research, published by Lippincott Williams & Wilkins, is a premier journal within the fields of orthopaedics and sports medicine, boasting a distinguished history since its inception in 1963. With an impressive impact factor and ranking within the top quartile (Q1) in multiple categories, including Medicine (miscellaneous), Orthopedics and Sports Medicine, Sports Science, and Surgery, this journal consistently delivers high-quality, peer-reviewed research that shapes contemporary practices and advancements in these critical areas. The journal is a vital resource for researchers, clinicians, and students, offering impactful studies and clinical trials that inform evidence-based practice and elevate the standards of patient care. With a strong commitment to the dissemination of innovative findings, Clinical Orthopaedics and Related Research serves as an essential platform for the exchange of ideas and discoveries that drive the future of orthopaedic health.

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.

JBI Evidence Implementation is a pioneering peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the field of evidence-based practice across multiple healthcare disciplines. With the ISSN 2691-3321 and an impressive range of quartile rankings in 2023, including Q1 in Nursing and Q2 in Internal Medicine and Public Health, this journal serves as a vital platform for researchers, practitioners, and students looking to enhance their understanding of the application of evidence in practical settings. Operating under an open access model, JBI Evidence Implementation facilitates the dissemination of high-quality research that impacts patient care and clinical outcomes. Positioned among the top quartiles in its field, the journal nurtures the growth of innovative methodologies and encourages interdisciplinary collaboration to tackle today’s healthcare challenges. For those invested in the field, this journal represents a crucial resource for evidence implementation, ensuring the translation of research into effective health services.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

International Journal of Telemedicine and Applications is a premier open-access journal published by HINDAWI LTD, focused on the rapidly evolving field of telemedicine and health informatics. With an ISSN of 1687-6415 and E-ISSN of 1687-6423, this journal has been a key resource for researchers, healthcare professionals, and students since its inception in 2007. Based in Egypt, the journal has established a global presence, reflected in its diverse range of articles that cover topics from computer networks to health information management. Its impact is underscored by its impressive rankings in Scopus, including notable positions such as 34th in Health Informatics and 15th in Health Information Management. The journal is classified in Q2 quartiles for four influential categories, showcasing its relevance and contribution to the field. With an ongoing publication timeline from 2008 to 2024, International Journal of Telemedicine and Applications is crucial for advancing knowledge and practice in telemedicine, offering researchers and practitioners the opportunity to explore innovative solutions in healthcare delivery.

The Journal of the American Medical Informatics Association, published by Oxford University Press, stands as a premier publication within the field of Health Informatics, showcasing cutting-edge research and innovative practices. With an impressive Q1 category ranking in 2023 and a remarkable Scopus rank of #6 out of 138, this journal consistently contributes to the advancement of knowledge and application in medical informatics, making it a vital resource for researchers, healthcare professionals, and students alike. Since its inception in 1994, the journal has fostered interdisciplinary collaboration and provides a platform for high-quality research that drives improvements in healthcare practices and technology. Although it operates on a subscription model, the journal's impactful findings and comprehensive analyses are essential for those looking to stay at the forefront of health informatics innovations.

The Cochrane Database of Systematic Reviews is a premier journal published by WILEY, focusing on the critical appraisal and synthesis of high-quality research in health care. With its dedication to evidence-based practice, this journal serves as a cornerstone for researchers, healthcare professionals, and students alike, offering pivotal insights through rigorous systematic reviews. Although it is not an open-access publication, its influence in guiding clinical decision-making and policy formulation is profound, underscored by its contributions to the advancement of healthcare knowledge. Based in the United States at 111 River St, Hoboken, NJ, the Cochrane Database has established itself as essential reading for those seeking to stay at the forefront of systematic reviews and meta-analyses in the medical field, ensuring that users are well-equipped with the evidence necessary for informed practice.

Circulation-Cardiovascular Quality and Outcomes, published by LIPPINCOTT WILLIAMS & WILKINS, stands as a leading journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and ranking in the Q1 category for both Cardiology and Cardiovascular Medicine, as well as in the broader field of Medicine (miscellaneous) as of 2023. With a dedicated focus on enhancing cardiovascular health through high-quality research, this journal disseminates vital findings that address clinical practice, healthcare delivery, and policy improvements. Operating under a rigorous peer-review process, it offers a platform for innovative studies and evidence-based insights essential for researchers, healthcare professionals, and students committed to advancing cardiovascular care. Although not an open-access journal, its contributions are invaluable to the ongoing dialogue within the medical community, driving essential changes and advancements in cardiovascular outcomes.

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.